The Worldwide Monoclonal Antibodies Industry is Expected to Reach $329.6 Billion by 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Monoclonal Antibodies Market 2020-2030 by Source, Category, Production Type, Application, End User, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

Global monoclonal antibodies market will reach $329.6 billion by 2030, growing by 10.9% annually over 2020-2030, driven by the increasing incidences of new cancer cases and other diseases, growth in geriatric population, increasing pharmaceutical R&D spending, upsurge in healthcare expenditure, and the rising adoption of cost-efficient biosimilar monoclonal antibodies.

Key Players:

• Abbott Laboratories
• AbbVie, Inc.
• Amgen Inc.
• AstraZeneca plc
• Bayer AG
• Bristol-Myers Squibb Company
• Eli Lilly
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co., Inc.
• Mylan N.V
• Norvatis AG
• Pfizer
• Sanofi S.A.

The report is based on a comprehensive research of the entire global monoclonal antibodies market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.

The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global monoclonal antibodies market in every aspect of the classification from perspectives of Source, Category, Production Type, Application, End User, and Region.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of Covid-19 on World Economy

2.1.2 Impact of Covid-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter's Five Forces Analysis

3 Segmentation of Global Market by Source

3.1 Market Overview by Source

3.2 Human

3.3 Humanized

3.4 Chimeric

3.5 Murine

4 Segmentation of Global Market by Category

4.1 Market Overview by Category

4.2 Branded Mabs

4.3 Biosimilar Mabs

5 Segmentation of Global Market by Production Type

5.1 Market Overview by Production Type

5.2 in Vitro Production

5.3 in Vivo Production

6 Segmentation of Global Market by Application

6.1 Market Overview by Application

6.2 Cancer

6.2.1 Breast Cancer

6.2.2 Colorectal Cancer

6.2.3 Lung Cancer

6.2.4 Ovarian Cancer

6.2.5 Other Cancer Types

6.3 Autoimmune Diseases

6.4 Inflammatory Diseases

6.5 Infectious Diseases

6.6 Other Applications

7 Segmentation of Global Market by End-user

7.1 Market Overview by End-user

7.2 Hospitals

7.3 Research Institutes

7.4 Other End-users

8 Segmentation of Global Market by Region

9 Competitive Landscape

9.1 Overview of Key Vendors

9.2 New Product Launch, Partnership, Investment, and M&A

9.3 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/7gls5o